Elos Medtech's Swedish language Annual and Sustainability Report for the fiscal year 2020 has been published and is now available on the Group's website, www.elosmedtech.com
The Annual Report for 2020 marks the first time the sustainability report as well as the sustainability notes have been integrated with the Annual Report. The printed version of the Annual Report will from late April be distributed to shareholders who have requested a copy to be sent to them by post. The English version will be available at the website in May.
About Elos Medtech
Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China, and the U.S. The customer base comprises international medical technology companies.Elos Medtech has more than 500 employees and a turnover of more than SEK 550 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech's B share is categorized as a Health Care company on the Small Cap list.
Göteborg, March 31, 2021
Elos Medtech AB (publ)
For further information, please contact:
Jan Wahlström, CEO, +46 70 212 18 89, firstname.lastname@example.org
Ewa Linsäter, CFO, 076 633 32 33, email@example.com
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This information is such that Elos Medtech AB (publ) is obliged to make public pursuant to the Securities Market Act.
The information was submitted for publication on March 31, 2021, at 08:30 (CET).
This information was distributed by Cision http://www.cisionwire.se/